Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05053438 · ClinicalTrials.gov registry record · NA
Evaluating Hunger Manipulation During Feeding Intervention
A NA study of Avoidant Restrictive Food Intake Disorder and Feeding and Eating Disorders, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 2
- Study locations
NCT05053438: Completed NA study of Avoidant Restrictive Food Intake Disorder and Feeding and Eating Disorders, sponsored by Emory University.
NCT05053438 is a NA study of Avoidant Restrictive Food Intake Disorder and Feeding and Eating Disorders that has completed, run by Emory University. The registered enrollment target is 16 participants, below the 4,050-participant average among 5 other Avoidant Restrictive Food Intake Disorder trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05053438, a NA study of Avoidant Restrictive Food Intake Disorder and Feeding and Eating Disorders, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary objective of this study is to determine to what extent hunger provocation, via rapid weaning from enteral feedings, is acceptable and feasible and to evaluate the effect of this intervention when used in an intensive multidisciplinary feeding intervention (IMFI) model of treatment (standard care), for individuals with Avoidant Food Intake Disorder (ARFID) who are dependent on enteral feedings to meet their daily caloric needs.
Primary Outcome
The percent oral intake will be calculated by dividing calories consumed during therapeutic meals by the daily calorie target.
Conditions Studied
Interventions
- BEHAVIORAL Intensive Multidisciplinary Feeding Intervention (IMFI)-Standard of Care
- BEHAVIORAL Intensive Multidisciplinary Feeding Intervention (IMFI) standard of care + rapid tube weaning
Study Locations (2)
Georgia
- Center for Advanced Pediatrics - Atlanta
- Marcus Autism Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2023-10-18 |
| Phase | NA |
What the finished NCT05053438 record still lists
NCT05053438 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 4,050-participant average among 5 other Avoidant Restrictive Food Intake Disorder trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Avoidant Restrictive Food Intake Disorder appearing as the primary indexed condition, and to 2 interventions - of which Intensive Multidisciplinary Feeding Intervention (IMFI)-Standard of Care is the first listed.
NCT05053438 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT05053438 about?
NCT05053438 is a clinical study titled "Evaluating Hunger Manipulation During Feeding Intervention". The primary objective of this study is to determine to what extent hunger provocation, via rapid weaning from enteral feedings, is acceptable and feasible and to evaluate the effect of this intervention when used in an intensive multidisciplinary feeding intervention (IMFI) model of treatment (stand...
What is the current status of trial NCT05053438?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2021-07-01. Estimated completion is 2023-10-18.
What conditions does trial NCT05053438 study?
This clinical trial studies the following conditions: Avoidant Restrictive Food Intake Disorder, Feeding and Eating Disorders, Feeding Disorders.
What interventions are being tested in trial NCT05053438?
The interventions under investigation include: Intensive Multidisciplinary Feeding Intervention (IMFI)-Standard of Care (BEHAVIORAL), Intensive Multidisciplinary Feeding Intervention (IMFI) standard of care + rapid tube weaning (BEHAVIORAL).
Who is sponsoring clinical trial NCT05053438?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05053438 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Avoidant Restrictive Food Intake Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia
RECRUITING · NA
-
Confirming the Efficacy/Mechanism of Family Therapy for Children With Low Weight ARFID
COMPLETED · NA
-
Eating Disorders Genetics Initiative 2
RECRUITING
-
The Use of Cyproheptadine in Pediatric Feeding Disorders
ACTIVE NOT RECRUITING · Phase 4
-
CGM in Patients With ED's
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI